Gladstone NOW: The Campaign Join Us on the Journey ✕
1381 - 1395 of 1429 Results Clear All
SAN FRANCISCO, CA—April 25, 2011—A scientist at the Gladstone Institutes has made two significant stem-cell discoveries that advance medicine and human health by creating powerful new approaches for using stem cells and stem-cell-like technology.
SAN FRANCISCO, CA—April 16, 2011—Scientists at the Gladstone Institutes have identified networks of genes that play an important role in embryonic-heart development, advancing knowledge of how healthy hearts develop—and offering clues about how to combat a common birth defect known as congenital
SAN FRANCISCO, CA—March 9, 2011—The Gladstone Institutes, a leading biomedical-research organization, today announced its participation in a bold new consortium intended to help the global community better identify, prevent and treat outbreaks of new or re-emerging viruses. Dr.
San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.
Gladstone Experts HIV/AIDS
SAN FRANCISCO, CA—December 16, 2010—The Massachusetts General Hospital (MGH) announced today that Shinya Yamanaka, MD, PhD, will receive the 2011 Warren Triennial Prize. Dr. Yamanaka discovered a method to convert adult cells into cells with characteristics of embryonic stem cells.
SAN FRANCISCO, CA—December 1, 2010—For the AIDS community, Thanksgiving came a bit early this year, and after many difficult years, three announcements give hope and reason for celebration during this year's World AIDS Day.
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) in San Francisco have discovered a new strategy to prevent memory deficits in a mouse model of Alzheimer's disease.
Alzheimer’s Disease Mucke Lab
SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.
Greene Lab HIV/AIDS
San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov
Grant Lab HIV/AIDS
SAN FRANCISCO, CA—November 2, 2010—A new center called the National Resource for Network Biology (NRNB) will help researchers and clinicians analyze an ever-growing wealth of complex biological data and apply that knowledge to real problems and diseases.
SAN FRANCISCO, CA—Alzheimer's disease is an extremely complicated disease. Several proteins seem to be involved in its cause and progression.
Alzheimer’s Disease Huang Lab
SAN FRANCISCO, CA—October 10, 2010—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found that an enzyme associated with the storage of fat in the liver is required for the infectious activity of the hepatitis C virus (HCV).
SAN FRANCISCO, CA—Amyloid beta (Αβ) proteins, widely thought to cause Alzheimer's disease, block the transport of vital cargoes inside brain cells.
Alzheimer’s Disease Mucke Lab
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts.
Srivastava Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.
Akassoglou Lab Multiple Sclerosis
